Correction to: Experimental & Molecular Medicine
https://doi.org/10.1038/s12276-025-01586-y, published online 18 November 2025
In the original version of this article, the given and family names of Renpeng Peng were incorrectly structured. The name was displayed correctly in all versions at the time of publication.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Peng, R., Zheng, M., Kang, H. et al. Author Correction: Methyl-CpG-binding domain 2 mitigates osteoarthritis through Steap3 promoter methylation and chondrocyte ferroptosis regulation. Exp Mol Med (2026). https://doi.org/10.1038/s12276-025-01620-z
Published:
Version of record:
DOI: https://doi.org/10.1038/s12276-025-01620-z
